Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone In Patients With Incurable Lung or Non- Colorectal Gastrointestinal Malignancies

Protocol: 
AAAP2609
Phase: 
III

Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone In Patients With Incurable Lung or Non- Colorectal Gastrointestinal Malignancies

The study intervention consists of the early integration of palliative care services into standard oncology care in an outpatient setting for patients with advanced lung and non-colorectal gastrointestinal malignancies who are not being treated with curative intent. The palliative care services provided to patients randomized to the intervention will be provided by board certified physicians and/or advanced practice nurses and will focus on the following areas: (1) developing and maintaining the therapeutic relationship with the patients and family caregivers; (2) assessing and treating patient symptoms; (3) providing support and reinforcement of coping with advanced cancer in patients and family caregivers; (4) assessing and enhancing prognostic awareness and illness understanding in patients and family caregivers; (5) assisting with treatment decision-making; and (6) end-of-life care planning.

Are you Eligible? (Inclusion Criteria)

1. Confirmed incurable lung cancer (NSCLC, small cell lung cancer, and mesothelioma) or non-colorectal GI cancer (esophageal, gastric, hepatic, biliary, or pancreatic) not being treated with curative intent
2. Diagnosed with incurable disease within the previous 8 weeks
3. ECOG Performance Status 0-2
4. Ability to read and respond to questions in English or able to complete questions with minimal assistance required from an interpreter or family member.

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States